Skip to Content

New Drug Shows Promise in Preventing Severe COVID-19

WEDNESDAY, Sept. 16, 2020 -- A single infusion of an experimental drug dramatically lowers levels of coronavirus in the bodies of newly infected patients and cuts their chances of hospitalization, the drug's maker reported Wednesday.

Eli Lilly's announcement did not include detailed data and has not been peer-reviewed or published yet, The New York Times reported. The news comes from interim results of a trial sponsored by Eli Lilly and the U.S. National Institutes of Health. NIH officials would not comment on the announcement until they have seen more detailed data from the trial, according to The Times.

The drug is a monoclonal antibody, a man-made copy of an antibody produced by a patient who recovered from COVID-19, The Times reported. Scientists around the world have high hopes that monoclonal antibodies will prove to be powerful COVID-19 treatments, but they come with a caveat: They are difficult to manufacture and would take time to produce. In the trial, 452 newly diagnosed COVID-19 patients received the monoclonal antibody or a placebo infusion. Some 1.7 percent of those who got the drug were hospitalized compared with 6 percent of those who received placebo -- a 72 percent reduction in risk, Eli Lilly said.

At the same time, blood levels of the coronavirus plummeted among those who received the drug, and their symptoms were fewer and milder, The Times reported. This is the first treatment aimed at patients who are not already seriously ill and hospitalized, the newspaper added.

The New York Times Article

© 2021 HealthDay. All rights reserved.

Read this next

Pandemic Caused Many Women to Abandon Plans for More Children

THURSDAY, Sept. 16, 2021 -- Nearly half of mothers report they halted plans to have additional children because of the COVID-19 pandemic, according to a study published online...

COVID-19 Vaccines Prevent Hospitalizations in High-Risk Populations

THURSDAY, Sept. 16, 2021 -- COVID-19 vaccines are effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requiring hospitalization, intensive...

COVID-19 Vaccines for Children Under 12 Could Come This Fall: Fauci

WEDNESDAY, Sept. 15, 2021 -- Many parents hoping for COVID-19 vaccines for their children younger than 12 years may get their wish this fall, according to Anthony Fauci, M.D...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.